Boomerang MedicalHome PageNews Page NewYork-Presbyterian Enrolls First Patient in National Study of Sacral Nerve Stimulation Device for Inflammatory Bowel Disease For Marco B. Zoccali, MD, FACS, a colorectal surgeon at NewYork-Presbyterian/Columbia, sacral nerve stimulation (SNS) has…Arboretum_JDMay 3, 2023
Boomerang MedicalNews Page Boomerang Medical Announces First Patients Enrolled in Multi-Center Clinical Trial Boomerang Medical, a women-led bioelectronic medicine company, has announced the enrollment of the first patients…Arboretum_JDApril 17, 2023
Boomerang MedicalNews Page Bioelectronic Medicine Company Boomerang Medical Earns FDA Breakthrough Device Designation Boomerang Medical, a women-led bioelectronic medicine company, has been granted Breakthrough Device Designation from the…Arboretum_JDMarch 1, 2023
Boomerang MedicalHome PageNews Page Bioelectronic Medicine Company Boomerang Medical Raises $15M in Series A Financing Returning investor Arboretum Ventures, joined by Hatteras Venture Partners, to fuel Boomerang Medical’s accelerated clinical…Arboretum_JDNovember 1, 2022